Korea’s health authorities gave the green light to a local pharmaceutical company on Aug. 9 to sell the nation’s first vaccine for Japanese encephalitis.
Boyung Pharm developed an inactivated Vero cell-derived vaccine (Beijing strain), the Ministry of Food and Drug Safety (MFDS) said.
According to the MFDS, the vaccine was found to be safe, highly immunogenic and capable of inducing long-...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.